Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vyome Holdings (HIND) EBITDA (2016 - 2025)

Historic EBITDA for Vyome Holdings (HIND) over the last 11 years, with Q3 2025 value amounting to -$8.6 million.

  • Vyome Holdings' EBITDA fell 147232.76% to -$8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.6 million, marking a year-over-year decrease of 20650.53%. This contributed to the annual value of -$7.7 million for FY2024, which is 4976.27% up from last year.
  • As of Q3 2025, Vyome Holdings' EBITDA stood at -$8.6 million, which was down 147232.76% from -$2.8 million recorded in Q2 2025.
  • Vyome Holdings' EBITDA's 5-year high stood at -$547628.0 during Q3 2024, with a 5-year trough of -$37.5 million in Q4 2021.
  • In the last 5 years, Vyome Holdings' EBITDA had a median value of -$4.0 million in 2023 and averaged -$7.6 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 273139.62% in 2021, then skyrocketed by 8864.79% in 2023.
  • Over the past 5 years, Vyome Holdings' EBITDA (Quarter) stood at -$37.5 million in 2021, then surged by 55.5% to -$16.7 million in 2022, then surged by 88.65% to -$1.9 million in 2023, then tumbled by 268.21% to -$7.0 million in 2024, then decreased by 23.4% to -$8.6 million in 2025.
  • Its last three reported values are -$8.6 million in Q3 2025, -$2.8 million for Q2 2025, and -$2.2 million during Q1 2025.